International Society for the Study of Xenobiotics

What International Society for the Study of Xenobiotics does

The International Society for the Study of Xenobiotics (ISSX) is a 501(c)(3) nonprofit scientific society incorporated in New Jersey on March 20, 1981, and headquartered at 3502 Woodview Trace, Suite 300, Indianapolis, IN. ISSX serves 1,000+ scientific members in more than 45 countries working on the metabolism and disposition of xenobiotics (drugs, environmental chemicals, and other foreign compounds) in biological systems. Its member base spans university researchers, pharmaceutical/biotech scientists, regulatory agency scientists (e.g., FDA), and students/early-career investigators, with regional structures covering North America, Europe, and Asia Pacific plus a newer Africa Initiative.

ISSX's core offering is a tiered membership program: Regular Member ($175/year), Student/Postdoc ($35), Premier Member ($330, which adds full ISSX Learning Center access), Premier Student/Postdoc ($70), Designated Country ($25, for World Bank low-income economy scientists), Emeritus (waived after 20 years of service and age 65+), and non-member Premier Access ($500). The technology stack is a proprietary society platform built around an online Learning Center (LMS hosting short courses, workshops, and meeting recordings), a webinar delivery system (Zoom-integrated), and a membership management backend (YourMembership). Complementary products include triennial International Scientific Meetings (every third year) and annual regional meetings in North America, Europe, and Asia Pacific; two official journals — Drug Metabolism and Pharmacokinetics (DMPK), free to members and hosted on ScienceDirect, and Drug Metabolism Reviews (DMR), subscription-based via Taylor & Francis; four Focus Groups (Bioanalysis in ADME Science, Biotransformation Mechanisms and Pathways, Modeling & Simulation, Transporters); a Mentorship Program; a New Investigators Group; an awards program (R.T. Williams Distinguished Scientific Achievement Award, Frederick J. Di Carlo Distinguished Service Award, regional achievement and new investigator awards); an ISSX Job Board; and the XenoXpress newsletter.

Revenue is generated through five streams: recurring membership dues, conference registration fees (with member discounts), journal access (largely pass-through distribution via Taylor & Francis/Elsevier), tiered corporate sponsorships ($1,001-$25,000+ across Bronze through Global Partner tiers), and industry-sponsored webinars at $5,000 per event, supplemented by individual donations. Go-to-market is community-led: recruitment flows through scientific meetings, member referrals, the New Investigators/Mentorship programs, and partnerships with sister societies (notably JSSX). The society operates with a 5-person staff and is governed by a Council split across the three historical regions.

Name

International Society for the Study of Xenobiotics

Legal name

International Society for the Study of Xenobiotics

Website

https://issx.org

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

1–10 employees

Short description

ISSX is a 501(c)(3) nonprofit scientific society founded in 1981 serving 1,000+ drug-metabolism researchers across 45+ countries via membership programs, scientific meetings, two official journals, the Learning Center, mentorship, focus groups, and corporate-sponsored awards.

Ownership category

akta.pro rank

Product category

Professional Scientific Society Services

NAICS

Professional Organizations (81392)

akta.pro industry

PRIMARYEDAFAAAB

Learning Experience Platforms (LXP) & Learning Portals

Education/Education Technology (EdTech) & Digital Learning/Learning Management Systems (LMS) & Learning Experience Platforms (LXP)

SECONDARYBPACANAH

Learning Technology & LMS/LXP Implementation

Business & Public Services/HR, Staffing & Recruitment Services/Training, Learning & Development Services

SECONDARYEDAGAKAF

Learning Experience Design (LXD) & UX for Learning

Education/Educational Publishing & Learning Content/Instructional Design & Content Development Services

Keywords

• Drug metabolism research
• Scientific society membership
• Pharmacokinetics education
• Xenobiotic science
• Scientific publications

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: Annual membership fees from Regular, Student, Postdoc, Premier, and Emeritus members provide recurring revenue. Effective January 5, 2026, membership begins on payment day and is valid for one full year.
2. Scientific Meetings and Conferences: Registration fees for regional meetings (North America, Europe, Asia Pacific) and international meetings held every third year. Members receive significant discounts on registration fees.
3. Journal Publications: Access to official journals Drug Metabolism Reviews (DMR) and Drug Metabolism and Pharmacokinetics (DMPK). DMPK is free to all ISSX members; DMR is subscription-based.
4. Corporate Sponsorships: Corporate support program with tiers: Global Partner ($25,000+), Gold Partner ($15,000-$24,999), Silver Partner ($5,001-$14,999), Bronze Partner ($1,001-$5,000). Includes meeting sponsorships and exhibitor fees.
5. Industry-Sponsored Webinars: Financial support for sole sponsorship of industry-sponsored webinars at $5,000 per event.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

ISSX is a membership-based scientific society that delivers annual memberships (Regular, Student/Postdoc, Designated Country, Emeritus, Premier tiers), international and regional scientific meetings, two peer-reviewed journals (DMPK and Drug Metabolism Reviews), an online Learning Center with courses and recordings, free educational webinars, focus groups, mentorship programs, awards, and a job board for the global drug metabolism and pharmacokinetics research community.

Product overview

ISSX operates as a scientific society offering membership-based programs and services. The core offerings include annual membership tiers (standard and Premier), access to scientific meetings (international triennial and regional), the ISSX Learning Center with online courses, webinars, focus groups, mentorship and new investigator programs, two official journals (DMPK and DMR), an awards program, and a job board. Premier Membership adds full Learning Center access including short courses and workshop recordings. The society connects researchers in drug metabolism and xenobiotic sciences through events, publications, and professional development opportunities.

Differentiator

Problem solved

Functional benefit

Products and services

• ISSX Membership Annual membership providing access to scientific meetings, webinars, the DMPK Journal, travel grants, awards, focus groups, mentorship program, and the member directory. Available in Regular, Student/Postdoc, Designated Country, Emeritus, and Premier tiers.
• ISSX Scientific Meetings International Meetings held every third year and regional meetings in North America, Europe, and Asia Pacific. Includes short courses, symposia, lectures, workshops, and abstract presentations with discounted registration for members.
• ISSX Learning Center Online educational platform offering short courses, workshops, and meeting recordings hosted at learn.issx.org. Premier Members have full access; standard members can access materials six months after live events.
• ISSX Webinars Free online educational webinars hosted via Zoom featuring world-renowned speakers covering topics in metabolism and disposition of xenobiotics. Includes both member-hosted and industry-sponsored formats ($5,000 per sole-sponsored event).
• Drug Metabolism and Pharmacokinetics (DMPK) Journal Official online journal of ISSX and JSSX publishing original research on drug metabolism, pharmacokinetics, biotransformation, and related topics. Free access for all ISSX members. Hosted on ScienceDirect (Elsevier).
• Drug Metabolism Reviews (DMR) Journal Subscription-based journal providing critical reviews of drug metabolism research covering established and new drugs, environmental toxic chemicals, and enzymology across all living species. Published by Taylor & Francis.
• ISSX Mentorship Program Matching program pairing graduate students and new investigators with senior scientists for career guidance, competency review, and professional advice.
• ISSX Africa Initiative Regional initiative promoting ISSX activities in Africa, providing training for early career researchers and supporting DMPK and clinical science development on the continent.
• ISSX Corporate Support Program Tiered corporate partnership/sponsorship program with Bronze, Silver, Gold, and Global Partner tiers supporting ISSX meetings, webinars, and programs.

Quantifiable outcome

• Members receive significant reduction on registration fees for all ISSX regional and international meetings
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Japanese Society for the Study of Xenobiotics (JSSX)coreStrategic or Co-development PartnerISSX maintains a joint partnership with JSSX for the Drug Metabolism and Pharmacokinetics (DMPK) journal, which is the official online journal of both societies. They also co-organize joint meetings including the ISSX/JSSX Meeting.
• Taylor & FranciscoreOthersTaylor & Francis publishes Drug Metabolism Reviews (DMR), an official ISSX journal that provides critically needed reviews of drug metabolism research.
• ScienceDirect (Elsevier)coreOthersScienceDirect hosts Drug Metabolism and Pharmacokinetics (DMPK), the official online journal of ISSX and JSSX.
• BioIVTminorGTM or Marketing PartnerPlatinum sponsor for ISSX 2025 International Meeting.
• PharmaronminorGTM or Marketing PartnerPlatinum sponsor for ISSX 2025 International Meeting.
• SciexminorGTM or Marketing PartnerPlatinum sponsor for ISSX 2025 International Meeting.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• American Chemical Society (ACS): Very large general scientific society whose Division of Chemical Toxicology and Medicinal Chemistry touches on xenobiotic and drug metabolism research, competing for sponsorships, journals, and members.
• Drug Information Association (DIA): Large, established global association covering the full drug development lifecycle including regulatory, safety, and clinical; competes with ISSX for industry sponsorships and conferences in adjacent drug metabolism/regulatory topics.
• International Pharmaceutical Federation (FIP): Global federation of national pharmaceutical associations; broader pharmacy/sciences umbrella that overlaps with ISSX's pharmaceutical scientist base and serves as a higher-level convening body.

Direct peers

• American Society for Pharmacology and Experimental Therapeutics (ASPET): U.S.-based pharmacology society covering drug metabolism, pharmacokinetics, and toxicology — overlapping significantly with ISSX's member base in academia and industry, and competing for similar scientific content and meeting attendance.
• American Association of Pharmaceutical Scientists (AAPS): Pharmaceutical sciences society with strong coverage of ADME/pharmacokinetics; overlapping industry scientist membership and competing for sponsorships, webinars, and meetings in the same drug development community.
• Society of Toxicology (SOT): Major toxicology and safety science society that overlaps with ISSX on the toxicology/xenobiotic interface, competing for regulator and industry scientist engagement and educational programming.
• Japanese Society for the Study of Xenobiotics (JSSX): Direct counterpart scientific society in Japan dedicated to xenobiotic/drug metabolism research; co-publishes the DMPK journal with ISSX and co-organizes joint meetings, making it the closest peer in scope and audience.

Regional players

• Federation of European Pharmacological Societies (EPHAR): Federation of European pharmacology societies; relevant regional counterpart that can absorb or channel European pharmacology programming that might otherwise sit with ISSX regional meetings.
• British Pharmacological Society: European pharmacology society with substantial DMPK and drug metabolism programming; comparable peer for European members and a parallel venue for ISSX's European scientists.
• EUROTOX: Federation of European Toxicologists & European Society of Toxicology in Vitro; another European scientific society overlapping with ISSX on xenobiotic safety and toxicology content.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/issx-the-international-society-for-the-study-of-xenobiotics
• Xx.com/issx
• Facebookfacebook.com/ISSXNews

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Society for the Study of Xenobiotics